Generation of trisomy 21 induced pluripotent stem cells
Generation of trisomy 21 induced pluripotent stem cells
批准号:
7942741
负责人:
ANITA BHATTACHARYYA
金额:
$18.56万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-02-29
关键词:
AffectAlzheimer&aposs DiseaseBiomanufacturingBrainCell LineCell modelCellsCharacteristicsChromosomesChromosomes, Human, Pair 21ClinicalCommunitiesCongenital Heart DefectsCoupledCraniofacial AbnormalitiesDataDefectDevelopmentDevelopmental ProcessDown SyndromeEmbryoEnvironmentEquipmentEvaluationFibroblastsGenerationsGeneticGoalsHousingHumanImmune systemImpairmentIndividualKnowledgeLeadLifeMental RetardationMental Retardation and Developmental Disabilities Research CentersMissionModelingMolecularNerve DegenerationNervous system structureNeurologicNeuronal DifferentiationNeuronsNeurosciencesNon-Viral VectorOrganPluripotent Stem CellsPredispositionProcessProsencephalonPsyche structurePublic HealthReagentReportingResearchResearch PersonnelResearch PriorityResourcesServicesSourceStem Cell ResearchStem cellsSynapsesSystemTestingTissuesTrisomyUniversitiesValidationViralWisconsinWorkabstractingbasecell typedevelopmental diseaseembryonic stem cellexperiencehuman diseaseinduced pluripotent stem cellinnovationinterestleukemiamouse modelneurodevelopmentneurogenesisprogramsrelating to nervous systemresearch studysuccess
中文摘要
描述(由申请人提供):唐氏综合征(DS),或21三体,是最常见的遗传发育障碍,导致精神发育迟滞。小鼠模型暗示神经发生减少和突触发育缺陷是DS精神障碍特征的重要贡献者。虽然小鼠模型至关重要,但它们无法解释人类大脑发育的所有复杂性,因此在人类细胞的背景下研究21三体的影响非常重要。DS中的人类神经发育尚未得到很好的研究。研究特定细胞类型发育的一种创新方法是使用人类多能干细胞。这项探索性的提议旨在利用最近关于诱导多能干细胞(iPS细胞)的报道来创造唐氏综合征特异性多能干细胞,以促进对人类神经发育的分析。该提议的第一个目的是从携带21三体的人成纤维细胞诱导多能干细胞。第二个目标将通过测试将这些三体21 iPS细胞分化为功能性前脑神经元的可行性来利用这种新资源。这种人类21三体神经元培养模式的建立将使研究能够解剖唐氏综合征中至少三个重要研究重点的分子机制:神经发生,突触发育和功能以及神经变性。公共卫生相关性:唐氏综合症是智力迟钝最常见的遗传原因,是一个公共卫生问题。这项研究将建立一个新的唐氏综合征模型,以推进唐氏综合征神经病理生理学的研究。该提案的目的包括从非胚胎来源中制造唐氏综合征特异性人类多能干细胞。
英文摘要
DESCRIPTION (provided by applicant): Down Syndrome (DS), or trisomy 21, is the most common genetic developmental disorder that leads to mental retardation. Mouse models have implicated reduced neurogenesis and faulty synaptic development as important contributors to the mental impairment characteristic of DS. While mouse models are crucial, they cannot explain all the complexities of human brain development making it important to examine the effects of trisomy 21 in the context of human cells. Human neural development in DS has not been well studied. An innovative way to study the development of particular cell types is through the use of human pluripotent stem cells. This exploratory proposal aims to take advantage of recent reports of induced pluripotent stem cells (iPS cells) to create Down syndrome-specific pluripotent stem cells to facilitate analysis of human neural development. The first aim of this proposal is to induce pluripotent stem cells from human fibroblasts that carry the trisomy 21. The second aim will exploit this new resource by testing the feasibility of differentiating these trisomy 21 iPS cells into functional forebrain neurons. The establishment of this human trisomy 21 neuronal culture paradigm will enable studies dissecting the molecular mechanisms of at least three important research priorities in Down syndrome: neurogenesis, synapse development and function, and neurodegeneration. PUBLIC HEALTH RELEVANCE: As the most common genetic cause of mental retardation, Down syndrome is a public health concern. The proposed research will create a new model of Down syndrome to advance the study of Down syndrome neuropathophysiology. The aims of this proposal include making Down syndrome-specific human pluripotent stem cells from non-embryonic sources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Supplement to TR01 Human cortical development and neural plasticity altered by trisomy 21
-
批准号:10670626
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2022
-
负责人:ANITA BHATTACHARYYA
-
依托单位:
Modeling Histone Demethylase Function in Neurogenesis
-
批准号:10527660
-
项目类别:
-
资助金额:$41.43万
-
财政年份:2022
-
负责人:ANITA BHATTACHARYYA
-
依托单位:
Human cortical development and neural plasticity altered by trisomy 21
-
批准号:10296076
-
项目类别:
-
资助金额:$700.59万
-
财政年份:2021
-
负责人:ANITA BHATTACHARYYA
-
依托单位:
T21RS meeting June 2019 Barcelona meeting grant
-
批准号:9763218
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2019
-
负责人:ANITA BHATTACHARYYA
-
依托单位:
Defining interneuron deficits in Down syndrome brain.
-
批准号:9034147
-
项目类别:
-
资助金额:$8.01万
-
财政年份:2015
-
负责人:ANITA BHATTACHARYYA
-
依托单位:
Astrocytes in Down Syndrome Synaptogenesis
-
批准号:7875449
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2010
-
负责人:ANITA BHATTACHARYYA
-
依托单位:
Generation of trisomy 21 induced pluripotent stem cells
-
批准号:7739054
-
项目类别:
-
资助金额:$21.21万
-
财政年份:2009
-
负责人:ANITA BHATTACHARYYA
-
依托单位: